Testimonials

Not only our science has to evolve — also our way of doing microbiome research and understanding multi-omics. Without Eagle Genomics, we would learn something from each scientific study, but it wouldn’t go anywhere beyond that.

By revealing relationships between microbiome data entities and relevant multi-omics data, Eagle Genomics' platform will further enable Cargill to advance its understanding of the complex association between the microbiome and digestive and immune health in humans and animals.

Product development in many divisions at Unilever is becoming increasingly data driven. Democratization of in-silico analytics and sharing insights in real time will be a key enabler.

With the use of Eagle Genomics’ platform, Reckitt has been able to accelerate scientific discovery of novel antimicrobial compounds beyond traditional capabilities — especially important given today’s health landscape.

We are delighted to be enabling such a pioneering company such as Cargill to explore microbiome data for food and digestive health, an area we believe over the next decade will be completely transformed by microbiome discovery. We look forward to a future of industry-disrupting food and nutraceutical products for humans and animals coming from inspirational brands like Cargill, informed by our platform.

The world needs us to get at innovations and new technologies at a much faster pace than we historically have, so we are partnering with people like Eagle Genomics.

Innovation is achieved through the data we collect, the insights we learn, the science we perform in collaboration with some of the best academic leaders in the space, and the data pipelines we build in partnership with Eagle Genomics.